354 related articles for article (PubMed ID: 12763797)
1. Functional properties of the human copper-transporting ATPase ATP7B (the Wilson's disease protein) and regulation by metallochaperone Atox1.
Lutsenko S; Tsivkovskii R; Walker JM
Ann N Y Acad Sci; 2003 Apr; 986():204-11. PubMed ID: 12763797
[TBL] [Abstract][Full Text] [Related]
2. Metallochaperone Atox1 transfers copper to the NH2-terminal domain of the Wilson's disease protein and regulates its catalytic activity.
Walker JM; Tsivkovskii R; Lutsenko S
J Biol Chem; 2002 Aug; 277(31):27953-9. PubMed ID: 12029094
[TBL] [Abstract][Full Text] [Related]
3. Human copper-transporting ATPase ATP7B (the Wilson's disease protein): biochemical properties and regulation.
Lutsenko S; Efremov RG; Tsivkovskii R; Walker JM
J Bioenerg Biomembr; 2002 Oct; 34(5):351-62. PubMed ID: 12539962
[TBL] [Abstract][Full Text] [Related]
4. The N-terminal metal-binding site 2 of the Wilson's Disease Protein plays a key role in the transfer of copper from Atox1.
Walker JM; Huster D; Ralle M; Morgan CT; Blackburn NJ; Lutsenko S
J Biol Chem; 2004 Apr; 279(15):15376-84. PubMed ID: 14754885
[TBL] [Abstract][Full Text] [Related]
5. The role of the invariant His-1069 in folding and function of the Wilson's disease protein, the human copper-transporting ATPase ATP7B.
Tsivkovskii R; Efremov RG; Lutsenko S
J Biol Chem; 2003 Apr; 278(15):13302-8. PubMed ID: 12551905
[TBL] [Abstract][Full Text] [Related]
6. Functional properties of the copper-transporting ATPase ATP7B (the Wilson's disease protein) expressed in insect cells.
Tsivkovskii R; Eisses JF; Kaplan JH; Lutsenko S
J Biol Chem; 2002 Jan; 277(2):976-83. PubMed ID: 11677246
[TBL] [Abstract][Full Text] [Related]
7. Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B.
de Bie P; van de Sluis B; Burstein E; van de Berghe PV; Muller P; Berger R; Gitlin JD; Wijmenga C; Klomp LW
Gastroenterology; 2007 Oct; 133(4):1316-26. PubMed ID: 17919502
[TBL] [Abstract][Full Text] [Related]
8. Copper transporting P-type ATPases and human disease.
Cox DW; Moore SD
J Bioenerg Biomembr; 2002 Oct; 34(5):333-8. PubMed ID: 12539960
[TBL] [Abstract][Full Text] [Related]
9. Molecular modelling of the nucleotide-binding domain of Wilson's disease protein: location of the ATP-binding site, domain dynamics and potential effects of the major disease mutations.
Efremov RG; Kosinsky YA; Nolde DE; Tsivkovskii R; Arseniev AS; Lutsenko S
Biochem J; 2004 Aug; 382(Pt 1):293-305. PubMed ID: 15147237
[TBL] [Abstract][Full Text] [Related]
10. The Wilson's disease protein expressed in Sf9 cells is phosphorylated.
Vanderwerf SM; Lutsenko S
Biochem Soc Trans; 2002 Aug; 30(4):739-41. PubMed ID: 12196182
[TBL] [Abstract][Full Text] [Related]
11. The distinct roles of the N-terminal copper-binding sites in regulation of catalytic activity of the Wilson's disease protein.
Huster D; Lutsenko S
J Biol Chem; 2003 Aug; 278(34):32212-8. PubMed ID: 12794172
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional insights of Wilson disease copper-transporting ATPase.
Fatemi N; Sarkar B
J Bioenerg Biomembr; 2002 Oct; 34(5):339-49. PubMed ID: 12539961
[TBL] [Abstract][Full Text] [Related]
13. Function and regulation of the mammalian copper-transporting ATPases: insights from biochemical and cell biological approaches.
Lutsenko S; Petris MJ
J Membr Biol; 2003 Jan; 191(1):1-12. PubMed ID: 12532272
[TBL] [Abstract][Full Text] [Related]
14. The Lys1010-Lys1325 fragment of the Wilson's disease protein binds nucleotides and interacts with the N-terminal domain of this protein in a copper-dependent manner.
Tsivkovskii R; MacArthur BC; Lutsenko S
J Biol Chem; 2001 Jan; 276(3):2234-42. PubMed ID: 11053407
[TBL] [Abstract][Full Text] [Related]
15. Sequence variation in the ATP-binding domain of the Wilson disease transporter, ATP7B, affects copper transport in a yeast model system.
Hsi G; Cullen LM; Macintyre G; Chen MM; Glerum DM; Cox DW
Hum Mutat; 2008 Apr; 29(4):491-501. PubMed ID: 18203200
[TBL] [Abstract][Full Text] [Related]
16. The distinct functional properties of the nucleotide-binding domain of ATP7B, the human copper-transporting ATPase: analysis of the Wilson disease mutations E1064A, H1069Q, R1151H, and C1104F.
Morgan CT; Tsivkovskii R; Kosinsky YA; Efremov RG; Lutsenko S
J Biol Chem; 2004 Aug; 279(35):36363-71. PubMed ID: 15205462
[TBL] [Abstract][Full Text] [Related]
17. Copper specifically regulates intracellular phosphorylation of the Wilson's disease protein, a human copper-transporting ATPase.
Vanderwerf SM; Cooper MJ; Stetsenko IV; Lutsenko S
J Biol Chem; 2001 Sep; 276(39):36289-94. PubMed ID: 11470780
[TBL] [Abstract][Full Text] [Related]
18. NMR characterization of copper-binding domains 4-6 of ATP7B .
Fatemi N; Korzhnev DM; Velyvis A; Sarkar B; Forman-Kay JD
Biochemistry; 2010 Oct; 49(39):8468-77. PubMed ID: 20799727
[TBL] [Abstract][Full Text] [Related]
19. ATP7B (WND) protein.
Terada K; Schilsky ML; Miura N; Sugiyama T
Int J Biochem Cell Biol; 1998 Oct; 30(10):1063-7. PubMed ID: 9785470
[TBL] [Abstract][Full Text] [Related]
20. Biochemical basis of regulation of human copper-transporting ATPases.
Lutsenko S; LeShane ES; Shinde U
Arch Biochem Biophys; 2007 Jul; 463(2):134-48. PubMed ID: 17562324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
